Cargando…
The purinergic receptor subtype P2Y(2) mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease
Idiopathic pulmonary fibrosis (IPF) is a devastating disease with few available treatment options. Recently, the involvement of purinergic receptor subtypes in the pathogenesis of different lung diseases has been demonstrated. Here we investigated the role of the purinergic receptor subtype P2Y(2) i...
Autores principales: | Müller, Tobias, Fay, Susanne, Vieira, Rodolfo Paula, Karmouty-Quintana, Harry, Cicko, Sanja, Ayata, Korcan, Zissel, Gernot, Goldmann, Torsten, Lungarella, Giuseppe, Ferrari, Davide, Di Virgilio, Francesco, Robaye, Bernard, Boeynaems, Jean-Marie, Blackburn, Michael R., Idzko, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482630/ https://www.ncbi.nlm.nih.gov/pubmed/28415591 http://dx.doi.org/10.18632/oncotarget.16414 |
Ejemplares similares
-
P2Y(6) Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary Fibrosis
por: Müller, Tobias, et al.
Publicado: (2017) -
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
por: Cicko, Sanja, et al.
Publicado: (2015) -
Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI)
por: Cicko, Sanja, et al.
Publicado: (2018) -
P2rx4 deficiency in mice alleviates allergen-induced airway inflammation
por: Zech, Andreas, et al.
Publicado: (2016) -
Role of purinergic signaling in experimental pneumococcal meningitis
por: Zierhut, Marco, et al.
Publicado: (2017)